COVID-19 Vaccine Safety: Focus on Vaccine-Induced Myocarditis
Peter A. McCullough, MD, MPH, FACC, FAHA, FASN, FNKF, FNLA
Chief Medical Advisor, Truth for Health Foundation
Editor-in-Chief, Reviews in Cardiovascular Medicine
Senior Associate Editor, American Journal of Cardiology
Tagline: https://americaoutloud.com/the-mccullough-report/
@PeterMcCulloughMD
Dr. McCullough is an internist, cardiologist, epidemiologist. He maintains ABIM certification in internal medicine and cardiovascular diseases. He practices both internal medicine including the management of common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA. Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 51 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill, FOX NEWS Channel, NewsMax, Real America, and America Out Loud. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, New Hampshire Senate, and South Carolina Senate concerning many aspects of the pandemic response. Dr. McCullough has dedicated his academic and clinical efforts in combating the SARS-CoV-2 virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world's experts on COVID-19.
After months of negative media coverage, the Guillain-Barre reports brought an overdue end to the swine flu affair. Ford’s programme was suspended in December 1976 with only some 20% of the US population (55M) vaccinated leaving 550 cases of Guillain-Barre and 25 deaths And since the US government had offered liability coverage to the pharmaceutical manufacturers that summer, hundreds of compensation claims from Guillain-Barre claimants followed for years afterward.
Outline
Outline
Clinical Concerns
-mRNA or adenoviral DNA induce production of the Spike protein
-Cell, tissue, organ endothelial damage
-Spike protein circulation (body fluids, donated blood)
-No genotoxicity, teratogenicity, or oncogenicity studies
-Concerning ovarian biodistribution study (Pfizer, Japan)
-Concerning reduced fertility study (Moderna, EMA)
-No EAC, DSMB, Human Ethics Committee
-No restriction of properly excluded groups from RCTs
-Pregnant women, women of childbearing potential
-COVID survivors, previously immune
-No effort to restrict vaccination according to risk for COVID-19 hospitalization and death
-No attempts to present or mitigate risks for public
EAC=events adjudication committee; DSMB=data safety monitoring board; EMA=European Medicines Agency
Outline
Emerging COVID-19 Vaccine Mortality Signal by Jan 22, 2021 (~27.1 M)
All vaccines before 2020
~158 total deaths/yr
Historical PreCOVID ~280M Injections/year:
All ~70 vaccines average expected 16,320 VAERS total reports/yr, ~158 total deaths/yr
Day of Death after
COVID-19 Vaccination
86% of deaths had no other explanation other than the vaccine
McLachlan, Scott & Osman, Magda & Dube, Kudakwashe & Chiketero, Patience & Choi, Yvonne & Fenton, Norman. (2021). Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim Results and Analysis. 10.13140/RG.2.2.26987.26402.
https://www.researchgate.net/publication/352837543_Analysis_of_COVID-19_vaccine_death_reports_from_the_Vaccine_Adverse_Events_Reporting_System_VAERS_Database_Interim_Results_and_Analysis
Mclachlan, Scott & Osman, Magda & Dube, Kudakwashe & Chiketero, Patience & Choi, Yvonne & Fenton, Norman. (2021). Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim Results and Analysis. 10.13140/RG.2.2.26987.26402.
COVID-19 Respiratory Infection Deaths
COVID-19 Vaccine Deaths
“A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to COVID-19 in the most vulnerable 65+ demographic”
From 0-20 weeks post injection there were 146-187k vaccine associated deaths
Outline
213 cases
10 years
5.5 M People
4 cases/1M/Yr
( J Am Heart Assoc. 2017;6:e005306. DOI: 10.1161/JAHA.116.005306.)
Outline
Conclusions